Salter Malcolm 4
4 · C4 Therapeutics, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Salter Malcolm
Director
Transactions
- Award
Common Stock
2022-01-04$31.58/sh+428$13,516→ 11,380 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022.